冠動脈疾患の診断と治療に関する新技術：2007年

Abstract

Coronary artery disease is a leading cause of death in the developed world and, as such, is at the forefront of medical research.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 CORONARY ARTERY DISEASE

• 1.1 Introduction
• 1.2 An Overview of Coronary Artery Disease
• 1.3 Epidemiology
• 1.4 Existing Diagnosis and Treatment Options for Coronary Artery Disease
  • 1.4.1 Diagnosis
  • 1.4.2 Treatment
• 1.5 Future Outlook

2.0 DIAGNOSTIC IMAGING DEVICES

• 2.1 Overview
• 2.2 Intravascular Ultrasound
  • 2.2.1 Technology Overview
  • 2.2.2 Market Potential
  • 2.2.3 Competitor Insights
• 2.3 Vulnerable Plaque Diagnosis
  • 2.3.1 Technology Overview
    • 2.3.1.1 Computed Tomography
    • 2.3.1.2 Magnetic Resonance Imaging
    • 2.3.1.3 Near-Infrared Spectroscopy
    • 2.3.1.4 Optical Coherence Tomography
    • 2.3.1.5 Thermography
  • 2.3.2 Market Potential
  • 2.3.3 Competitor Insights
    • 2.3.3.1 Computed Tomography
    • 2.3.3.2 Magnetic Resonance Imaging
    • 2.3.3.3 Near-Infrared Spectroscopy
    • 2.3.3.4 Optical Coherence Tomography
    • 2.3.3.5 Thermography

3.0 REVASCULARIZATION DEVICES

• 3.1 Overview
• 3.2 Novel Stent Technologies
  • 3.2.1 Technology Overview
    • 3.2.1.1 Bioabsorbable Stents
    • 3.2.1.2 Specially Coated Drug-Eluting Stents
  • 3.2.2 Market Potential
    • 3.2.2.1 Bioabsorbable Stents
    • 3.2.2.2 Specially Coated Drug-Eluting Stents
    • 3.2.2.3 Overall Coronary Stent Market
  • 3.2.3 Competitor Insights
    • 3.2.3.1 Bioabsorbable Stents
    • 3.2.3.2 Specially Coated Drug-Eluting Stents
• 3.3 Synthetic Grafts
  • 3.3.1 Technology Overview
  • 3.3.2 Market Potential
  • 3.3.3 Competitor Insights
• 3.4 Remote Navigation Technologies
  • 3.4.1 Technology Overview
  • 3.4.2 Market Potential
  • 3.4.3 Competitor Insights

4.0 NEOVASCULARIZATION THERAPIES

• 4.1 Overview
• 4.2 Therapeutic Angiogenesis
  • 4.2.1 Technology Overview
    • 4.2.1.1 Gene Therapy
    • 4.2.1.2 Stem Cell Therapy
  • 4.2.2 Market Potential
  • 4.2.3 Competitor Insights
    • 4.2.3.1 Gene Therapy
    • 4.2.3.2 Stem Cell Therapy

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: ADDITIONAL COMPETITOR INFORMATION

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: New Imaging Technology Procedures, US, 2009-2018
• Exhibit 2: PCIs, by Type, US, 2018
• Exhibit 3: Therapeutic Angiogenesis Procedures, US, 2013-2018

CHAPTER 1: CORONARY ARTERY DISEASE

• Exhibit 4: Frequently Used CAD Terminology
• Exhibit 5: Stages of Lesion Development
• Exhibit 6: Common CAD Risk Factors
• Exhibit 7: Global Life Expectancy, 2006
• Exhibit 8: CAD Incidence, by Region, 2007-2013 (Tabular Format)
• Exhibit 9: Symptoms of CAD
• Exhibit 10: CAD Treatment Options

CHAPTER 2: DIAGNOSTIC IMAGING DEVICES

• Exhibit 11: IVUS Procedures, by Region, 2006-2011
• Exhibit 12: New Imaging Technology Penetration, as a % of Total, US, 2009-2018
• Exhibit 13: New Imaging Technology Penetration, US, 2009-2018

CHAPTER 3: REVASCULARIZATION DEVICES

• Exhibit 14: BAS Procedures, US, 2012-2018
• Exhibit 15: BAS Penetration, US, 2012-2018
• Exhibit 16: SCDES Procedures, US, 2010-2018
• Exhibit 17: SCDES Penetration, US, 2010-2018
• Exhibit 18: PCIs, by Type, as a % of Total, US, 2008-2018
• Exhibit 19: PCIs, by Type, US, 2008-2018
• Exhibit 20: PCI Growth, by Type, US, 2008-2018
• Exhibit 21: BAS in Development, 2007
• Exhibit 22: BAS Material Absorption Time
• Exhibit 23: Polymer-Free and Bioabsorbable Polymer-Coated Stents, 2007
• Exhibit 24: Synthetic Graft Procedures, 2011-2018
• Exhibit 25: Synthetic Graft Penetration, 2011-2018
• Exhibit 26: RNT Procedures, 2008-2018
• Exhibit 27: RNT Penetration, US, 2008-2018

CHAPTER 4: NEOVASCULARIZATION THERAPIES

• Exhibit 28: Therapeutic Angiogenesis Procedures, US, 2013-2018
• Exhibit 29: Therapeutic Angiogenesis Procedure Penetration, US, 2013-2018

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: ADDITIONAL COMPETITOR INFORMATION